Archive

Post Archive: Alex Spira MD PhD FACP

Virginia Cancer Specialists » VCS Practice News » Physicians » VCS Practice News » Alex Spira MD PhD FACP » Page 3

Alexander Spira, MD, PhD, FACP, on the recent approval of atezolizumab in SCLC

Alex Spira MD PhD FACP, Lung Cancer
April 2, 2019
Read More

Virginia Cancer Specialists (VCS) Now Offering a Newly FDA-Approved Targeted Therapy for Acute Leukemia

Alex Spira MD PhD FACP, Clinical Trials and Research, Hematology and Blood Cancers, Leukemia, Dipti Patel-Donnelly MD
February 4, 2019
Read More

Advancements in Science and Cancer Care Research Announced at the US Oncology Research 17th Annual Science Forum - Dr. Alex Spira

The Research Institute, Alex Spira MD PhD FACP
October 8, 2018
Read More

Co Author Alex Spira, MD - Lung Cancer Study Treatment Option for ALK Positive Lung Cancer Patients

Alex Spira MD PhD FACP, Lung Cancer
September 25, 2018
Read More

Alex Spira, M.D., PhD, F.A.C.P. receives award for his work in Lung Cancer

Alex Spira MD PhD FACP, Lung Cancer
September 20, 2018
Read More

Virginia Cancer Specialists Collaborating with Caris Life Sciences to Present New Molecular Findings at the 2018 ASCO Annual Meeting

The Research Institute, Alex Spira MD PhD FACP, Amy J. Irwin MD
May 22, 2018
Read More

Dr. Alex Spira quoted in announcement from Mirati Theraputics: Progress Of Lead Programs And Updated Positive Clinical Trial Results For Immuno-Oncology Combination Trials

Alex Spira MD PhD FACP, Immunotherapy, Clinical Trials and Research
April 26, 2018
Read More

Virginia Cancer Specialists first patient successfully completes Cycle 1 of Treatment with PCM-075 combination with Low Dose Cytarabine (LDAC) AML Trial

The Research Institute, Alex Spira MD PhD FACP, Clinical Trials and Research, Leukemia
March 6, 2018
Read More

Alex Spira, MD Co-Author of collaborative study on Immunotherapy guidelines to guide clinicians and patients

Alex Spira MD PhD FACP, Immunotherapy
February 15, 2018
Read More

Virginia Cancer Specialists enrolls fist patient in Phase 1b/2 Clinical Trial of PCM-075 for Acute Myeloid Leukemia (AML)

Clinical Trials Search, The Research Institute, Alex Spira MD PhD FACP, Clinical Trials and Research, Leukemia
February 7, 2018
Read More
Return to Top